ReviewSeminars in nephrology2011
Contrast-induced acute kidney injury: short- and long-term implications.
Review in Seminars in nephrology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 77 citations in OpenAlex.
- Short-term effects of empagliflozin on preventing contrast induced acute kidney injury in patients undergoing percutaneous coronary intervention, a randomised trial.Scientific reports · 2025Trial
- Alprostadil plays a protective role in contrast-induced nephropathy in the elderly.International urology and nephrology · 2013Trial
- Impact of contrast volume on medium- to long-term renal function in patients undergoing repeated percutaneous coronary interventions.International journal of cardiology. Heart & vasculature · 2026Article
- Comparative Evaluation of Clinical and Immunonutritional Risk Scores for Predicting Contrast-Associated Acute Kidney Injury in Emergency Patients.Diagnostics (Basel, Switzerland) · 2025Article
- Left main percutaneous or surgical revascularisation and subsequent risk of transient and persistent renal dysfunction.Open heart · 2025Article
- Efficacy of Coronary Sinus Aspiration in Reducing Contrast-Induced Nephropathy in High-Risk Patients.JACC. Advances · 2025Article
- The association between sodium-glucose cotransporter 2 inhibitors and contrast-associated acute kidney injury in patients with type 2 diabetes undergoing angiography: a propensity-matched study.European journal of medical research · 2024Article
- Contrast-Induced Acute Kidney Injury in Radiology: Recent Insights and Advances.Journal of pharmacy & bioallied sciences · 2024Article
- Strategies for Renal Protection in Cardiovascular Interventions.Korean circulation journal · 2022Review
- Mechanism ofFrontiers in nephrology · 2022Review
- Risk of Worsening Renal Function Following Repeated Exposures to Contrast Media During Percutaneous Coronary Interventions.Journal of the American Heart Association · 2021Article
- Stanniocalcin-1 Alleviates Contrast-Induced Acute Kidney Injury by Regulating Mitochondrial Quality Control via the Nrf2 Pathway.Oxidative medicine and cellular longevity · 2020Article
- Physical Training Is a Potential Modifier of Risk for Contrast-Induced Acute Kidney Injury in Diabetes Mellitus.BioMed research international · 2020Article
- Contrast Induced Acute Kidney Injury and its Impact on Mid-Term Kidney Function, Cardiovascular Events and Mortality.Scientific reports · 2019Observational
- Relationship between High Level of Estimated Glomerular Filtration Rate and Contrast-Induced Acute Kidney Injury in Patients who Underwent an Emergency Percutaneous Coronary Intervention.Chinese medical journal · 2018Article
- Maximum allowable contrast dose and prevention of acute kidney injury following cardiovascular procedures.Current opinion in nephrology and hypertension · 2018Review
- Effects of Iodixanol on Respiratory Functions during Coronary Angiography and the Role of Body Composition.Cardiology research and practice · 2018Article
- Predictive value of inflammatory factors on contrast-induced acute kidney injury in patients who underwent an emergency percutaneous coronary intervention.Clinical cardiology · 2017Article
- Understanding and preventing contrast-induced acute kidney injury.Nature reviews. Nephrology · 2017Review
- Statins in the prevention of contrast-induced nephropathy.Current treatment options in cardiovascular medicine · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
The intravascular administration of iodine-based contrast media remains a common cause of acute kidney injury and a leading cause of iatrogenic renal disease. Past research has elucidated the principal risk factors for contrast-induced acute kidney injury (CIAKI) and helped to establish the efficacy of various interventions for the prevention of this condition. The importance of preventing CIAKI has been underscored by a growing number of studies showing strong associations of CIAKI with serious adverse short- and long-term outcomes. However, it remains unclear whether these associations are causal. This is important because considerable health care resources are used to prevent CIAKI. If CIAKI is a marker, but not a mediator, of serious adverse downstream outcomes, more judicious and selective use of preventive care may be appropriate. Moreover, with an increasing number of studies reporting the underuse of coronary angiography in patients with acute coronary syndrome and underlying chronic kidney disease, presumably in part because of a fear of CIAKI, a clear understanding of whether this condition directly results in adverse downstream outcomes is essential. Careful inspection of past studies that investigated the association of CIAKI with adverse short- and long-term events sheds light on their strengths and weaknesses and provides insight into how future research may be better able to characterize the short- and long-term implications of this iatrogenic condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.